+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia-Pacific Animal Vaccine Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: Asia Pacific
  • Orion Market Research Private Limited
  • ID: 4969033
Asia-Pacific Animal Vaccine Market Size, Share & Trends Analysis Report, By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) and Forecast, 2019-2025.

Asia-Pacific animal vaccine market is estimated to grow at a CAGR of around 7.6% during the forecast period. Asia-Pacific has a potential market owing to the increasing animal husbandry practices with an improvement in the management of farms. Moreover, the advancement in biotechnological research is supporting to drive the market in the region. The large breeding companies in the region are increasingly inclining towards the adoption of high-quality vaccines, which are nearly 5-15 times costly than vaccines purchased under the policy. Significant prevalence of livestock diseases is expected to offer bright prospects in the growth of the animal vaccine market in the region. Further, the rapid industrialization of the entire livestock, increasing state government initiatives with the introduction of several mass vaccination programs are some other factors augmenting the market growth in the region.

Some crucial players in the market include Zoetis, Inc., Bayer AG, Boehringer Ingelheim International GmbH, Hester Biosciences Ltd., Merck & Co., Inc., and Novartis International AG. In order to survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, R&D, and partnerships and collaborations. This enables the company to increase its competitiveness and attract significant share in the market. For instance, in June 2019, Biovet Pvt. Ltd. plans to invest nearly $28 million in India as a part of its expansion plans to meet the emerging demands, primarily to tackle Foot & Mouth disease and Brucellosis in animals across the country. The company will establish a new Brucella vaccine production facility at the Malur site in India to produce 100 million doses.

Research Methodology

The market study of the Asia-Pacific animal vaccine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for pharmaceuticals companies, veterinary Companies, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation
  • Asia-Pacific Animal Vaccine Market Research and Analysis, By Type
  • Asia-Pacific Animal Vaccine Market Research and Analysis, By Technology

The Report Covers
  • Comprehensive research methodology of the Asia-Pacific animal vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific animal vaccine market.
  • Insights about market determinants which are stimulating the Asia-Pacific animal vaccine market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Country
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Asia-Pacific Animal Vaccine Market by Type
5.1.1. Porcine Vaccines
5.1.2. Poultry Vaccines
5.1.3. Livestock Vaccines
5.1.4. Aquaculture Vaccines
5.1.5. Companion Animal Vaccines
5.1.6. Other Animal Vaccines
5.2. Asia-Pacific Animal Vaccine Market by Technology
5.2.1. Live Attenuated Vaccine
5.2.2. Killed/Inactive Vaccine
5.2.3. Recombinant Vaccine
5.2.4. Vectored Vaccine
5.2.5. Subunit Vaccine
5.2.6. DNA Vaccine
5.2.7. Chimeric Vaccine
5.2.8. Others
6. Regional Analysis
6.1. China
6.2. India
6.3. Japan
6.4. Rest of Asia-Pacific
7. Company Profiles
7.1. Bayer AG
7.2. Bio-Med (P) Ltd.
7.3. Biovet Pvt. Ltd.
7.4. Boehringer Ingelheim International GmbH
7.5. Brilliant Bio Pharma Private Limited (BBPL)
7.6. Hester Biosciences Ltd.
7.7. Indovax Pvt. Ltd.
7.8. Merck & Co., Inc.
7.9. Nisseiken Co. Ltd.
7.10. Novartis International AG
7.11. Zoetis, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bayer AG
  • Bio-Med (P) Ltd.
  • Biovet Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited (BBPL)
  • Hester Biosciences Ltd.
  • Indovax Pvt. Ltd.
  • Merck & Co., Inc.
  • Nisseiken Co. Ltd.
  • Novartis International AG
  • Zoetis, Inc.